Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Drug Price Reform Concerns Novartis Pharma President

An Interview With Novartis's Marie-France Tschudin

Sep 28 2021

• By Jessica Merrill

Novartis

Related Content

Blow For Novartis Eye Drug Beovu As Studies Stop On Safety Worries

Jun 01 2021

Novartis Challenger To Alexion Advances In Rare Kidney Disease

Jun 07 2021

Novartis Can Again Pursue Bigger Zolgensma Market After FDA Lifts OAV-101 Hold

Aug 03 2021

Novartis’s Tschudin On Launches, Drug Pricing And Lasting COVID Impacts

Sep 22 2021

Pharma On Its Back Foot As US Drug Price Reform Advances

Sep 08 2021

Medicare Price Negotiation Targeting Only Post-Exclusivity Drugs Proposed By Moderate House Democrats

Sep 16 2021

Related Companies

Novartis AG

Additional Topics

Commercial Leadership Pricing Debate Legislation Reimbursement Commercial Strategies BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window